B Cell News and Research

RSS

New understanding about malaria immunity could lead to the development of effective vaccines

Understanding how people exposed to malaria for the first time develop immunity could lead to creating more effective treatments including vaccines to fight the disease, researchers say.

9 Jun 2022

Olympus Provi™ CM20 wins highest honor in world-renowned design competition

Evident, a wholly owned subsidiary of Olympus Corporation, is proud to announce that its Olympus Provi™ CM20 incubation monitoring system is the 2022 recipient of the prestigious "Best of the Best" award in the Product Design category of the Red Dot Design Award. This Award is bestowed on a product that the Red Dot Jury deems as groundbreaking and is the highest honor given in this world-renowned design competition.

From Evident Corporation - Life Sciences 9 Jun 2022

Insights on the T cell epitope landscape for the five main SARS-CoV-2 variants of concern

Researchers generated an AI resource to characterize the T cell epitope landscape for SARS-CoV-2 variants of concern.

9 Jun 2022

Insilico Medicine plans to launch a fully automated AI-driven robotics lab for drug discovery

Insilico Medicine's end-to-end AI-driven drug discovery platform, Pharma.AI, draws its strength from the quality and quantity of its data. As Insilico scientific advisory board member and Nobel Prize laureate in chemistry Dr. Michael Levitt has said, Insilico's platform capitalizes on the ability of artificial intelligence to take vast amounts of data from many different components and find patterns and make predictions that can point the way to new life-saving medications.

9 Jun 2022

Stem cell models help determine previously unknown genetic markers of glaucoma

Stem cell models of the retina and optical nerve have been used to identify previously unknown genetic markers of glaucoma, in research jointly led by scientists from the Garvan Institute of Medical Research, the University of Melbourne, and the Centre for Eye Research Australia.

9 Jun 2022

Synthetic IL-9 receptor allows T cells to fight cancer without the need for chemo or radiation

Before a patient can undergo T cell therapy designed to target cancerous tumors, the patient's entire immune system must be destroyed with chemotherapy or radiation. The toxic side effects are well known, including nausea, extreme fatigue and hair loss.

8 Jun 2022

Research suggests two protein coding genes can predict severe COVID-19

In a recent study posted to the medRxiv* pre-print server, researchers demonstrated that two genes, GTPase, IMAP Family Member 7 (GIMAP7), and sphingosine-1-phosphate receptor 2 (S1PR2), have the potential to predict severe coronavirus disease 2019 (COVID-19) with ~90% accuracy.

8 Jun 2022

Study on the underlying biology of long COVID

In a recent article published in the Science Translational Medicine journal, researchers analyzed prolonged and unique implications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in humans and hamsters following recovery.

8 Jun 2022

Advanced microscopy techniques offer detailed insight into inner workings of cells' powerhouses

Using advanced microscopy techniques, researchers at Karolinska Institutet and Stockholm University in Sweden have visualized in unprecedented detail the machinery that the cells' powerhouses, the mitochondria, use to form their proteins.

8 Jun 2022

New therapeutic avoids major allergic reactions while maintaining therapeutic activity

Several years ago, a promising therapeutic using stem cell factor (SCF) emerged that could potentially treat a variety of ailments, such as ischemia, heart attack, stroke and radiation exposure.

8 Jun 2022

Zinc may reverse lung damage, improve survival for patients with idiopathic pulmonary fibrosis

Investigators from the Women's Guild Lung Institute at Cedars-Sinai have discovered that zinc, a common mineral, may reverse lung damage and improve survival for patients with a deadly age-related condition known as idiopathic pulmonary fibrosis (IPF).

8 Jun 2022

Targeting thalamic circuits could reverse Parkinson’s symptoms in mice

Parkinson's disease is best-known as a disorder of movement. Patients often experience tremors, loss of balance, and difficulty initiating movement. The disease also has lesser-known symptoms that are nonmotor, including depression.

8 Jun 2022

Detailed genetic roadmap of glaucoma will help develop new drugs to combat the disease

A new, detailed genetic roadmap of glaucoma – the world's leading cause of irreversible blindness – will help researchers develop new drugs to combat the disease, by identifying potential target areas to stall or reverse vision loss.

8 Jun 2022

New technology may enable rapid diagnosis of Ebola virus

A new tool can quickly and reliably identify the presence of Ebola virus in blood samples, according to a study by researchers at Washington University School of Medicine in St. Louis and colleagues at other institutions.

8 Jun 2022

New diagnostic procedure could help start optimal stroke treatment in a timely manner

A blood clot in the brain that blocks the supply of oxygen can cause an acute stroke. In this case, every minute counts.

8 Jun 2022

Open multiplexing with Cell DIVE offers cancer researchers more choices

Leica has introduced a new generation of its multiplexed imaging solution, Cell DIVE, including software and hardware improvements. The more scalable and efficient multiplexing platform addresses spatial cell biology and function within the tissue microenvironment

From Leica Microsystems GmbH 8 Jun 2022

Irregularities in production of brain cells may lead to autism spectrum disorder, finds study

Analyzing brain stem cells of patients with autism spectrum disorder (ASD), Rutgers scientists have found evidence of irregularities in very early brain development that may contribute to the neuropsychiatric disorder.

8 Jun 2022

Where did Omicron's unique spike gene insertion originate?

In a recent study posted to the medRxiv* pre-print server, scientists at nference Labs investigated the origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) new variant of concern (VOC) Omicron's unique spike (S) gene insertion ins214EPE.

8 Jun 2022

Targeted dietary measures can reduce the symptom burden in allergic reactions, trial shows

Micronutrient deficiencies can promote inflammation and render the immune system particularly sensitive to allergenic substances.

8 Jun 2022

Cofilin could be a potential target for mitigating atherosclerosis at early stage, finds study

A joint research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and Queen Mary University of London (QMUL) has discovered the molecular mechanisms of how pathological condition-mimicking mechanical stimuli lead to the early progression of atherosclerosis, a leading cause of vascular disease worldwide.

8 Jun 2022

B Cell News and Research

New understanding about malaria immunity could lead to the development of effective vaccines

Olympus Provi™ CM20 wins highest honor in world-renowned design competition

Insights on the T cell epitope landscape for the five main SARS-CoV-2 variants of concern

Insilico Medicine plans to launch a fully automated AI-driven robotics lab for drug discovery

Stem cell models help determine previously unknown genetic markers of glaucoma

Synthetic IL-9 receptor allows T cells to fight cancer without the need for chemo or radiation

Research suggests two protein coding genes can predict severe COVID-19

Study on the underlying biology of long COVID

Advanced microscopy techniques offer detailed insight into inner workings of cells' powerhouses

New therapeutic avoids major allergic reactions while maintaining therapeutic activity

Zinc may reverse lung damage, improve survival for patients with idiopathic pulmonary fibrosis

Targeting thalamic circuits could reverse Parkinson’s symptoms in mice

Detailed genetic roadmap of glaucoma will help develop new drugs to combat the disease

New technology may enable rapid diagnosis of Ebola virus

New diagnostic procedure could help start optimal stroke treatment in a timely manner

Open multiplexing with Cell DIVE offers cancer researchers more choices

Irregularities in production of brain cells may lead to autism spectrum disorder, finds study

Where did Omicron's unique spike gene insertion originate?

Targeted dietary measures can reduce the symptom burden in allergic reactions, trial shows

Cofilin could be a potential target for mitigating atherosclerosis at early stage, finds study

Industry focus eBook - Cell and gene therapy (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News